149 results
8-K
EX-4.2
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation … for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
8-K
EX-4.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental … prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
The purpose of this financial advisory agreement (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P … or relied upon for any other purpose. A.G.P. shall not have the authority to make any commitment binding on the Company. The Company agrees that A.G.P
8-K
EX-10.1
bryyhaws
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
EX-99.1
glun5b7z
7 Dec 23
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
8:41am
8-K
EX-10.1
ruwak2uyr9uff174q
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.3
jlyccqh
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.1
tf14 igpdu
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.2
m130 udonc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
uqf1l12qy 5k8qd6cqh9
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
EX-1.1
vd5yf1s8
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
424B5
3ykj0bfuva7t31
21 Jul 23
Prospectus supplement for primary offering
4:39pm
S-8
wp6oam6 ip2
14 Jul 23
Registration of securities for employees
5:12pm